Depressive symptoms during early adulthood and the development of physical multimorbidity in the UK: an observational cohort study
- PMID: 34901908
- PMCID: PMC8636278
- DOI: 10.1016/S2666-7568(21)00259-2
Depressive symptoms during early adulthood and the development of physical multimorbidity in the UK: an observational cohort study
Abstract
Background: An understanding of whether early-life depression is associated with physical multimorbidity could be instrumental for the development of preventive measures and the integrated management of depression. We therefore aimed to map out the cumulative incidence of physical multimorbidity over adulthood, and to determine the association between the presence of depressive symptoms during early adulthood and the development of physical multimorbidity in middle age.
Methods: In this observational cohort study, we used pooled data from the 1958 National Child Development Study (NCDS) and the 1970 British Cohort Study (BCS). Cohort waves were pooled in each decade of adult life available (when cohort members were aged 26 years in the BCS and 23 years in the NCDS [baseline]; 34 years in the BCS and 33 years in the NCDS [age 34 BCS/33 NCDS]; 42 years in the BCS and NCDS [age 42 BCS/NCDS]; and 46 years in the BCS and 50 years in the NCDS [age 46 BCS/50 NCDS]). We included participants who had completed the nine-item Malaise Inventory at baseline, and did not have a history of physical multimorbidity, any physical multimorbidity at baseline, or the presence of depressive symptoms before the development of physical multimorbidity. The presence of depressive symptoms was determined using the nine-item Malaise Inventory (cutoff score ≥4). Physical multimorbidity was defined as having at least two measures of any of the following ten self-reported groups of long-term conditions: asthma or bronchitis; backache; bladder or kidney conditions; cancer; cardiovascular conditions; convulsions or epilepsy; diabetes; hearing conditions; migraine; and stomach, bowel, or gall conditions. Cumulative incidence (with 95% CI) of physical multimorbidity was calculated for each decade considered after baseline, with physical multimorbidity being assessed as both a dichotomous and categorical variable. The association between depressive symptoms and the development of physical multimorbidity was assessed using adjusted relative risk ratios (with 95% CIs).
Findings: Analyses included 15 845 participants, of whom 4001 (25·25%; 95% CI 24·57-25·93) had depressive symptoms at baseline and 11 844 (74·75%; 74·07-75·42) did not. The cumulative incidence of physical multimorbidity (dichotomous) ranged over the study period from 2263 (18·44%; 95% CI 17·75-18·14) of 12 273 participants at age 34 BCS/33 NCDS, to 4496 (42·90%; 41·95-43·85) of 10 481 participants at age 46 BCS/50 NCDS, and was consistently higher in participants with depressive symptoms at baseline. The adjusted relative risk of physical multimorbidity was higher in participants with depressive symptoms than in those without and remained stable over the study period (adjusted relative rate ratio 1·67, 95% CI 1·50-1·87, at age 34 BCS/33 NCDS; 1·63, 1·48-1·79, at age 42 BCS/NCDS; and 1·58, 1·43-1·73, at age 46 BCS/50 NCDS).
Interpretation: The presence of depressive symptoms during early adulthood is associated with an increased risk of the development of physical multimorbidity in middle age. Although further research about the drivers of this relationship is needed, these results could help to enhance the integrated management of individuals with depressive symptoms and the development of preventive strategies to reduce the effect and burden of physical multimorbidity.
Funding: UK Medical Research Council and Guy's Charity.
© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Conflict of interest statement
MH is the principal investigator of the RADAR-CNS programme, a precompetitive public private partnership funded by the Innovative Medicines Initiative and European Federation of Pharmaceutical Industries and Associations. The programme receives support from Janssen, Biogen, Merck Sharp & Dohme, UCB, and Lundbeck. All other authors declare no competing interests.
Figures


Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study.Lancet Infect Dis. 2021 Aug;21(8):1184-1191. doi: 10.1016/S1473-3099(20)30978-6. Epub 2021 Mar 1. Lancet Infect Dis. 2021. PMID: 33662324 Free PMC article.
-
Depressive symptoms and the development and progression of physical multimorbidity in a national cohort of Australian women.Health Psychol. 2019 Sep;38(9):812-821. doi: 10.1037/hea0000738. Epub 2019 May 30. Health Psychol. 2019. PMID: 31144827
-
Associations between physical multimorbidity patterns and common mental health disorders in middle-aged adults: A prospective analysis using data from the UK Biobank.Lancet Reg Health Eur. 2021 Jun 22;8:100149. doi: 10.1016/j.lanepe.2021.100149. eCollection 2021 Sep. Lancet Reg Health Eur. 2021. PMID: 34557851 Free PMC article.
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
Cited by
-
Development of Visible Spectrophotometric Methods for the Determination of Tricyclic Antidepressants Based on Formation of Molecular Complexes with p-Benzoquinones.Int J Mol Sci. 2023 Nov 25;24(23):16744. doi: 10.3390/ijms242316744. Int J Mol Sci. 2023. PMID: 38069067 Free PMC article.
-
Prevalence of multimorbidity during 18 years in Denmark. A nationwide register study.J Multimorb Comorb. 2025 Apr 15;15:26335565251331182. doi: 10.1177/26335565251331182. eCollection 2025 Jan-Dec. J Multimorb Comorb. 2025. PMID: 40292304 Free PMC article.
-
Late-life depression and multimorbidity trajectories: the role of symptom complexity and severity.Age Ageing. 2023 Feb 1;52(2):afac315. doi: 10.1093/ageing/afac315. Age Ageing. 2023. PMID: 36735844 Free PMC article.
-
Physical long-term conditions and the effectiveness of England's NHS Talking Therapies programme for working-age adults: findings from a South London borough.BMJ Ment Health. 2025 May 19;28(1):e301632. doi: 10.1136/bmjment-2025-301632. BMJ Ment Health. 2025. PMID: 40389306 Free PMC article.
-
Prevalence of Antidepressant Prescriptions for Community-Dwelling Adults Diagnosed with Depressive Disorder in the UK: A Systematic Review.Psychiatr Q. 2024 Dec;95(4):731-746. doi: 10.1007/s11126-024-10093-8. Epub 2024 Sep 30. Psychiatr Q. 2024. PMID: 39347894
References
-
- Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43. - PubMed
-
- Arias de la Torre J, Ronaldson A, Valderas JM, et al. Diagnostic promiscuity: the use of real-world data to study multimorbidity in mental health. Br J Psychiatry. 2021;218:237–239. - PubMed
-
- Smith DJ, Court H, McLean G, et al. Depression and multimorbidity: a cross-sectional study of 1,751,841 patients in primary care. J Clin Psychiatry. 2014;75:1202–1208. - PubMed
-
- Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67:254–266. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical